OctoPlus publishes prospectus for listing of shares issued on 18 December 2009
Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET
Click here to directly access OctoPlus' Annual Report 2008
OctoPlus has increased its fill & finish capacity by expanding its GMP facility
OctoPlus' Supervisory Board is responsible for supervising the conduct of and providing advice to the Executive Board and supervising our business generally. In performing its duties, the Supervisory Board is required to act in the interests of our business as a whole. The Supervisory Board is currently composed of the following members:
| Hans Stellingsma | Chairman - Quintel |
| Rene Kuijten | Life Sciences Partners II B.V. |
| Philip Smith | Independent member |
| Paul Toon | Independent member |
| Frans Eelkman Rooda | Wessanen N.V. |
| James Gale | Signet Healthcare Partners |
Please click here to view the biographies of OctoPlus' Supervisory Board members.